博瑞医药 (688166.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(博瑞医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 340,133,145.781,179,517,532.47914,877,843.44587,482,000.41304,937,396.251,017,331,488.33772,321,355.75500,350,348.92248,373,219.05
 营业利润(元) 70,691,727.53190,244,378.17197,956,457.28113,543,624.8875,605,620.79242,155,215.52212,214,097.71120,834,949.8265,287,387.64
 利润总额(元) 70,586,962.95188,770,059.91197,688,288.52113,276,581.7375,605,622.55242,207,221.25212,497,638.28121,241,935.3165,299,553.52
 净利润(元) 61,809,832.36173,423,636.78176,740,694.8798,389,544.2466,044,611.76211,426,956.60177,878,679.31104,105,568.8757,800,875.06
 归属于母公司股东的净利润(元) 64,069,918.71202,466,024.77191,790,741.75109,440,368.5570,769,470.45239,623,172.71197,623,801.86112,001,271.8160,754,391.10
盈利能力:
 销售毛利率(%) 57.1755.7958.5856.0358.8863.0162.5061.9563.58
 销售净利率(%) 18.1714.7019.3216.7521.6620.7823.0320.8123.27
 净资产收益率(%) 2.718.888.845.253.43----
 总资产报酬率ROA(%) 1.674.394.903.002.01----
 投入资本回报率ROIC(%) 1.384.584.362.521.647.026.263.632.06
营运能力:
 存货周转率(次) 0.451.671.280.920.46----
 应收账款周转率(次) 1.244.032.511.600.84----
 总资产周转率(次) 0.070.240.200.130.07----
偿债能力:
 资产负债率(%) 51.3751.9550.8551.1250.4251.9150.7550.8548.21
 股东权益比率(%) 47.7147.0747.8947.7048.2647.0248.0147.5650.05
 已获利息倍数(倍) 7.058.829.167.259.4825.72-44.0949.609.28
 流动比率 1.781.992.152.162.172.392.242.322.83
 速动比率 1.351.531.661.681.721.961.771.852.17
发展能力:
 营业收入增长率(%) 11.5415.9418.4617.4122.77-3.333.194.4331.53
 营业利润增长率(%) -6.50-21.44-6.72-6.0315.80-6.506.341.0618.64
 税后利润增长率(%) -9.47-15.51-2.95-2.2916.48-1.7711.734.8025.00
 净资产增长率(%) 5.308.0721.2122.4926.9030.6023.9224.3122.63
 总资产增长率(%) 6.507.9521.5222.1431.5956.9756.3274.7270.70

前瞻产业研究院